The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
Full article >>
Sunday, April 19, 2009
Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment